CYP1A2 (Gene)

Organism:

Homo sapiens

Synonyms:CP12, CYP1A2, CYPIA2, ENTREZ:1544, HGNC:2596, MIM:124060, NM_000761, NP_000752, P3-450, P450(PA), cytochrome P450 family 1 subfamily A member 2

Omim:OMIM:124060

Id:a1062f61-aab5-5691-b6df-77ab31298033

Hgnc:HGNC:2596

Entrez:1544

Ensembl:ENSG00000140505

Description:cytochrome P450 family 1 subfamily A member 2

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CYP1A2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CYP1A2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CYP1A2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CYP1A2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CYP1A2.

Results found

Linked to

	Label	Description
	GSE143944 1 V 0 RIBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE158969 1 V 0 TRASTUZUMAB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 9 V 5 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE193258,GSE193259 9 V 13 OSIMERTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE228263 FDX1 overexpression SU-DHL-4 Elesclomol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228263 elesclomol SU-DHL-4 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119345 bexarotene T cell 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE118548 trametinib T84 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 6 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE163240 enzalutamide 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE143944 1 V 0 RIBOCICLIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE158969 1 V 0 TRASTUZUMAB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 9 V 5 SULFORAPHANE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE193258,GSE193259 9 V 13 OSIMERTINIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE228263 FDX1 overexpression SU-DHL-4 Elesclomol 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE228263 elesclomol SU-DHL-4 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE119345 bexarotene T cell 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE118548 trametinib T84 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 6 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE163240 enzalutamide 3 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.